Many surveys have shown that women using postmenopausal hormone therapy have a lower incidence of cardiovascular diseases and lower overall mortality.
The purpose of this study was to compare past and non-users with current users of hormone therapy in regard to characteristics known to, or assumed to, predict poor subsequent health (indicators).
The main data source was a survey in 1989 of a random sample (n=2000, 86% response rate) of 45-64 year-old Finnish women.
Among women with their uterus, after adjusting for age and urbanism, of the 21 indicators studied, 10 suggested a poorer and none a better health prognosis for the non-users than for current users.
Mots-clés Pascal : Traitement substitutif, Progestatif, Morbidité, Hormone, Oestrogène, Postménopause, Epidémiologie, Femme, Homme, Indicateur, Etat sanitaire, Facteur risque, Finlande, Europe
Mots-clés Pascal anglais : Replacement therapy, Progestagen, Morbidity, Hormone, Estrogen, Postmenopause, Epidemiology, Woman, Human, Indicator, Health status, Risk factor, Finland, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0343008
Code Inist : 002B02O. Création : 199406.